Renji Hospital
Renji Hospital
Shanghai, Shanghai Municipality, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma | Non-clear Cell Renal Cell Carcinoma | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05831891 |